IPO - ZyVersa Therapeutics, Inc.

Form Type: S-1/A

Filing Date: 2025-07-18

Corporate Action: Ipo

Type: Update

Accession Number: 000164117225020253

Filing Summary: ZyVersa Therapeutics, Inc. filed an amendment to its Form S-1 registration statement to register an offering of up to 23,624,938 shares of common stock. This offering includes shares to be sold by selling stockholders, comprised of shares issued under an Equity Purchase Agreement with Williamsburg Venture Holdings, LLC, and some shares associated with warrants. The company is pursuing these registrations following a business combination and to satisfy registration rights granted under the applicable agreements. The offering commenced following the necessity for an effective registration after prior trading was suspended on Nasdaq due to noncompliance with listing requirements. The common stock is now available for trading in the over-the-counter market. The document highlights the company's clinical development efforts and risk factors associated with the investment in their securities.